Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.048 AUD | +17.07% | +11.63% | -7.69% |
05:01am | Emyria Receives Grant to Develop MDMA Analog Drug Program; Shares Up 17% | MT |
20/06 | Emyria to Facilitate PTSD Treatment Trial | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-7.69% | 11.19M | |
-34.77% | 13.2B | |
+4.48% | 11.76B | |
-3.60% | 11.57B | |
+8.44% | 10.67B | |
+28.58% | 8.64B | |
-11.35% | 7.24B | |
+10.23% | 6.98B | |
+8.41% | 6.46B | |
-.--% | 4.99B |
- Stock Market
- Equities
- EMD Stock
- News Emyria Limited
- Australian Medical Regulator Grants ‘Authorized Prescriber’ Status to Emyria’s Specialist Psychiatrist; Shares Soar 19%